Hepatican Ltd presents at Lifted Ventures’ London Investor Showcase

Today, Hepatican Ltd participated in Lifted Ventures’ first London investor showcase, presenting its ground-breaking bioartificial liver technology to a room of venture capitalists and angel investors. Company founder Clare Selden showcased how HepatiCan™ could transform liver failure treatment, offering an “off-the-shelf” solution using lab-grown liver spheroids.

The event was part of the SBRI Healthcare and NIHR i4i Inc. Venture Capital Readiness Programme, aimed at helping health-tech innovators secure funding and scale their impact.